Galenica AG
GALE
Rank in Stocks
#3269
Galenica AG stands as a leading healthcare services company, serving both the... Galenica AG stands as a leading healthcare services company, serving both the Swiss market and international clients. Its operations are organized into two principal divisions: "Products & Care" and "Logistics & IT." The "Products & Care" division oversees an extensive network of 520 pharmacies, comprising 368 directly owned outlets and 152 partner-affiliated pharmacies, operating under the recognized brand names of Amavita, Sun Store, and Coop Vitality. Beyond retail pharmacy services, this segment also provides medication for patients receiving home-based treatment. It is also responsible for the introduction and distribution of a diverse portfolio of consumer health, pharmaceutical, and parapharmaceutical products, in addition to offering vital marketing and sales support to its collaborators within the healthcare sector. The "Logistics & IT" division specializes in offering a suite of pre-wholesale services tailored for pharmaceutical and healthcare enterprises. These services encompass essential functions such as secure storage, efficient distribution, and comprehensive debt collection. Furthermore, this segment provides various logistics and information technology solutions, including a master data system specifically developed for the healthcare industry. It actively creates advanced management solutions relevant to the healthcare market and publishes technical information on pharmaceutical products in both printed and electronic formats, alongside delivering complete management tools for pharmacies. Founded in 1927, Galenica AG maintains its headquarters in Bern, Switzerland.
Share Price
$107.82
Market Cap
$5.37B
Change (1 day)
0.62%
Change (1 year)
-4.43%
Country
CH
Trade Galenica AG (GALE)
Category
Healthcare
P/E ratio for Galenica AG (GALE)
P/E ratio as of October 2026 TTM: 27.85
According to Galenica AG latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 27.85. At the end of 2024 the company had a P/E ratio of 20.26.
P/E ratio history for Galenica AG from 2013 to 2026
P/E ratio at the end of each year
| Year | P/E Ratio | Change |
|---|---|---|
| 2026 (TTM) | 27.85 | 3.50% |
| 2025 | 26.91 | 32.87% |
| 2024 | 20.26 | -3.04% |
| 2023 | 20.89 | -8.19% |
| 2022 | 22.75 | 12.28% |
| 2021 | 20.26 | 19.69% |
| 2020 | 16.93 | -28.24% |
| 2019 | 23.59 | 64.85% |
| 2018 | 14.31 | -30.64% |
| 2017 | 20.63 | -19.97% |
| 2016 | 25.78 | -2.72% |
| 2015 | 26.50 | 0.87% |
| 2014 | 26.28 | 0.00% |
| 2013 | 0.00 | 0.00% |
P/E ratio for similar companies or competitors
| Company | P/E Ratio | P/E Ratio Difference | Country |
|---|---|---|---|
| 26.02 | -6.58% |
US
|
|
| 25.18 | -9.60% |
US
|
|
| 35.41 | 27.15% |
US
|
|
| 13.31 | -52.21% |
US
|
|
| 45.62 | 63.78% |
AU
|
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.